In vivo occipital-frontal temperature-gradient in schizophrenia patients and its possible association with psychopathology: A magnetic resonance spectroscopy study

European Neuropsychopharmacology

Volumn 18, Issue 8, 2008, Pages 557-564

  Shiloh, Roni ^a,b   Kushnir, Tammar ^c   Gilat, Yaron ^a   Gross Isseroff, Ruth ^a   Hermesh, Haggai ^a,b   Munitz, Hanan ^b   Stryjer, Rafael ^b,d   Weizman, Abraham ^a,b   Manor, David ^c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

Author keywords

Brain temperature; Magnetic resonance spectroscopy; Schizophrenia

Indexed keywords

HALOPERIDOL; LEVOMEPROMAZINE; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; RISPERIDONE; TRIHEXYPHENIDYL; WATER;

ADULT; ARTICLE; BRAIN TEMPERATURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; FRONTAL LOBE; HUMAN; IN VIVO STUDY; MALE; OCCIPITAL LOBE; PARANOID SCHIZOPHRENIA; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ASPARTIC ACID; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; SCHIZOPHRENIA; TEMPERATURE; WATER;

EID: 45949105778     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.04.007     Document Type: Article

References (92)

1. Akil M., Edgar C.L., Pierri J.N., Casali S., and Lewis D.A. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol. Psychiatry 47 (2000) 361-370
2. Andreasen N.C., Rezai K., Alliger R., Swayze V.W., Flaum M., Kirchner P., et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch. Gen. Psychiatry 49 (1992) 943-958
3. Andreasen N.C. A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. Arch. Gen. Psychiatry 56 (1999) 781-787
4. Andreasen N.C. Schizophrenia: the fundamental questions. Brain Res. Brain Res. Rev. 31 (2000) 106-112
5. Baldessarini R.J., and Frankenburg F.R. Clozapine. A novel antipsychotic agent. N. Engl. J. Med. 324 (1991) 746-754
6. Bligh J. The central neurology of mammalian thermoregulation. Neuroscience 4 (1979) 1213-1236
7. Buck C.W., Carscallen H.B., and Hobbs G.E. Temperature regulation in schizophrenia: I. Comparison of schizophrenic and normal subjects. II. Analysis by duration of psychosis. Arch. Neurol. Psychiatry 64 (1950) 828-842
8. Buck C.W., Carscallen H.B., and Hobbs G.E. The relation between oral and rectal temperatures in schizophrneic patients. Psychiatr. Q. 29 (1955) 28-32
9. Cady E.B., D'Souza P.C., Penrice J., and Lorek A. The estimation of local brain temperature by in vivo 1H magnetic resonance spectroscopy. Magn. Reson. Med. 33 (1995) 862-867
10. Cameron D.E. Heat production and heat control in the schizophrenic reaction. Arch Neurol. Psychiatry 32 (1934) 704-711
11. Cape G. Neuroleptic malignant syndrome - a cautionary tale and a surprising outcome. Br. J. Psychiatry 164 (1994) 120-122
12. Carlsson A., and Lindquist M. Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and norepinephrine in mouse brain. Acta Pharmacol. Toxicol. 20 (1963) 140
13. Chess-Williams R., and Broadley K. Temperature dependence of beta 1-adrenoceptor-mediated responses examined by use of partial agonists. Eur. J. Pharmacol. 108 (1985) 25-32
14. Childs C., Hiltunen Y., Vidyasagar R., Risto A., and Kauppinen R.A. Determination of regional brain temperature using proton magnetic resonance spectroscopy to assess brain-body temperature differences in healthy human subjects. Magn. Reson. Med. 57 (2007) 59-66
15. Chlan-Fourney J., Ashe P., Nylen K., Juorio A.V., and Li X.M. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Res. 954 (2002) 11
16. Chong T.W., and Castle D.J. Layer upon layer: thermoregulation in schizophrenia. Schizophr. Res. 69 (2004) 149-157
17. Corbett R.J., and Laptook A.R. Failure of localized head cooling to reduce brain temperature in adult humans. Neuroreport 9 12 (1998) 2721-2725
18. Corbett R.J., Laptook A.R., Tollefsbol G., and Kim B. Validation of a noninvasive method to measure brain temperature in vivo using 1H NMR spectroscopy. J. Neurochem. 64 (1995) 1224-1230
19. Corbett R.J., Purdy P.D., Laptook A.R., Chaney C., and Garcia D. Noninvasive measurement of brain temperature after stroke. AJNR Am. J. Neuroradiol. 20 10 (1999) 1851-1857
20. Coyle J.T. The glutamatergic dysfunction hypothesis for schizophrenia. Harv. Rev. Psychiatry 3 (1996) 241-253
21. Coyle J.T., Tsai G., and Goff D.C. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr. Drug Targets CNS Neurol. Disord. 1 (2002) 183-189
22. Coyle J.T., Tsai G., and Goff D.C. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. N. Y. Acad. Sci. 1003 (2003) 318-327
23. Coyle J.T., and Tsai G. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int. Rev. Neurobiol. 59 (2004) 491-515
24. Crow T.J. Positive and negative schizophrenia symptoms and the role of dopamine. Br. J. Psychiatry 139 (1981) 251-254
25. Deakin J.F., Slater P., Simpson M.D., Gilchrist A.C., Skan W.J., Royston M.C., et al. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52 (1989) 1781-1786
26. Deicken R.F., Zhou L., Corwin F., Vinogradov S., and Weiner M.W. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am. J. Psychiatry 154 (1997) 688-690
27. Diwadkar V.A., Chakraborty S., Murphy E., Benton M.D., and Keshavan M.S. Schizophrenia patients showed impaired hippocampal and prefrontal responses during associative learning: fMRI evidence of hypoactivation and dysplasticity. Proc. ISMRM, 15th Ann. Sci. Mtg (2007) 2215
28. Dixit S., Bushara K., and Brooks B. Epidemic heat stroke in a midwest community: risk factors, neurological complications and sequelae. Wisc. Med. J. 96 (1997) 39-41
29. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., and Thome J. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr. Res. 52 (2001) 79-86
30. Epstein J., Stern E., and Silbersweig D. Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies. Ann. N. Y. Acad. Sci. 877 (1999) 562-574
31. Esamai F., Mining S., Forsberg P., and Lewis D.H. A comparison of brain, core and skin temperature in children with complicated and uncomplicated malaria. J. Trop. Pediatr. 47 (2001) 170-175
32. Farkas T., Wolf A.P., Jaeger J., Brodie J.D., Christman D.R., and Fowler J.S. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Arch. Gen. Psychiatry 41 (1984) 293-300
33. Fujimotoa T., Takeuchb K., Matsumotob T., Kamimurab K., Hamadab R., Nakamurab K., and Kato N. Abnormal glucose metabolism in the anterior cingulated cortex in patients with schizophrenia. Psychiatr. Res. 154 (2007) 49-58
34. Fukuzako H., Fukuzako T., Hashiguchi T., Kodama S., Takigawa M., and Fujimoto T. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. Am. J. Psychiatry 156 (1999) 1205-1208
35. Fuller C.A., and Baker M.A. Selective regulation of brain and body temperatures in the squirrel monkey. Am. J. Physiol. 245 (1983) R293-R297
36. Glantz L.A., and Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch. Gen. Psychiatry 54 (1997) 943-952
37. Hasegawa H., Meeusen R., Sarre S., Diltoer M., Piacentini M.F., and Michotte Y. Acute dopamine/norepinephrine reuptake inhibition increases brain and core temperature in rats. J. Appl. Physiol. 99 (2005) 1397-1401
38. Hazlett E.A., Buchsbaum M.S., Jeu L.A., Nenadic I., Fleischm M.B., Shihabuddin L., Haznedar M.M., and Harvey P.D. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task. Schizophr. Res. 43 (2000) 33-46
39. Hazlett E.A., and Buchsbaum M.S. Sensorimotor gating deficits and hypofrontality in schizophrenia. Front Biosci. 6 (2001) 1069-1072
40. Heh C., Herrera J., Demet E., Potkin S., Costa J., Sramek J., et al. Neuroleptic-induced hypothermia associated with amelioration of psychosis in schizophrenia. Neuropsychopharmacol 1 (1988) 149-156
41. Hermesh H., Shiloh R., Epstein Y., Manaim H., Weizman A., and Munitz H. Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs. Am. J. Psychiatry 157 (2000) 1327-1329
42. Hiroi N., and Graybiel A. Typical and atypical neuroleptics stimulate contrasting patters of neuropeptide and Fos/FRA expression in the striatum. Soc. Neurosci. Abstracts 19 (1993) 129
43. Horrobin D.F. Schizophrenia: a biochemical disorder?. Biomedicine 32 (1980) 54-55
44. James J.R. Non-invasive absolute temperature imaging with TmDOTMA. Proc. ISMRM, 13th Ann. Sci. Mtg, Berlin, Germany (2007) 154
45. Joy K., and Senthilkumaran B. Annual and diurnal variations in, and effects of altered photoperiod and temperature, ovariectomy, and estradiol-17 beta replacement on catechol-O-methyltransferase level in brain regions of the catfish, Heteropneustes fossilis. Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol. 119 (1998) 37-44
46. Ju Z., Dunham R., and Liu Z. Differential gene expression in the brain of channel catfish (Ictalurus punctatus) in response to cold acclimation. Mol. Genet. Genomics 268 (2002) 87-95
47. Katz-Brull R., Alsop D.C., Marquis R.P., and Lenkinski R.E. Limits on activation-induced temperature and metabolic changes in the human primary visual cortex. Magnet. Res. Med. 56 (2006) 348-355
48. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13 (1987) 261-276
49. Kiyatkin E.A., and Brown P.L. Brain and body temperature homeostasis during sodium pentobarbital anesthesia with and without body warming in rats. Physiol. Behav. 84 (2005) 563-570
50. Klein W., and Riedel W. Long-term recording of core temperatures with chronically implanted silicon diodes. Pflugers Arch. 403 (1985) 55-57
51. Kauppinen R.A. Absolute brain temperature by 1H MRS. Proc. ISMRM, 15th Ann. Sci. Mtg (2007) 3380
52. Krebs M.O., Guillin O., Bourdell M.C., Schwartz J.C., Olie J.P., Poirier M.F., and Sokoloff P. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol. Psychiatry 5 (2000) 558-562
53. Maeir U., Aigner J., and Klein H. Hypothermia caused by neuroleptics. Two case reports and review of the literature. Nervenarzt 65 (1994) 488-491
54. Marshall I., Karaszewski B., Wardlaw J.M., Cvoro V., Wartolowska K., Armitage P.M., Carpenter T., Bastin M.E., Farrall A., and Haga K. Measurement of regional brain temperature using proton spectroscopic imaging: validation and application to acute ischemic stroke. Magn. Res. Imaging 24 (2006) 699-706
55. McIlvoy L. Comparison of brain temperature to core temperature: a review of the literature. J. Neurosci. Nurs. 36 (2004) 23-31
56. Meltzer H.Y. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 99 (1989) S18-S27
57. Meltzer H.Y. Serotonin2A receptors in schizophrenia: relation to suicide. Arch. Gen. Psychiatry 51 (1994) 1003-1004
58. Meltzer H.Y. The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics. J. Clin. Psychopharmacol. 15 (1995) 2S-3S
59. Molina V., Gispert J.D., Reig S., Sanz J., Pascau J., Santos A., Desco M., and Palomo T. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Psychopharmacology 178 (2005) 17-26
60. Molina V., Sanz J., Sarramea F., Benito C., and Palomo T. Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity. J. Psychiatr. Res. 39 (2005) 117-127
61. Mosteller R. Simplified calculation of body surface area. N. Engl. J. Med. 317 (1987) 1098
62. Nybo L., Moller K., Volianitis S., Nielsen B., and Secher N. Effects of hyperthermia on cerebral blood flow and metabolism during prolonged exercise in humans. J. Appl. Physiol. 93 (2002) 58-64
63. Overall J., and Gorham D. The Brief Psychiatric Rating Scale. Psychol. Rep. 10 (1961) 799-812
64. Rysa P., and Sarvaranta J. Corneal temperature in man and rabbit. Acta Ophthal. 52 (1974) 810-816
65. Samson R.S., Thornton J.S., McLean M.A., Williams S.C., and Tofts P.S. 1H-MRS internal thermometry in test-objects (phantoms) to within 0.1 K for quality assurance in long-term quantitative MR studies. NMR Biomed. 19 (2006) 560-565
66. Satinoff E. Neural organization and evolution of thermal regulation in mammals: several hierarchically arranged integrating systems may have evolved to achieve precise thermoregulation. Science 201 (1978) 16-22
67. Schmidt I., and Simon E. Temperature changes of the hypothalamus and body core in ducks feeding in cold water. Pflugers Arch. 378 (1979) 227-230
68. Scott J. A finite element model of heat transport in the human eye. Phys. Med. Biol. 33 (1988) 227-241
69. Shiloh R., Hermesh H., Weizer N., Dorfman-Etrog P., Weizman A., and Munitz H. Acute antipsychotic drug administration lowers body temperature in drug-free male schizophrenia patients. Eur. Neuropsychopharmacol. 10 (2000) 443-445
70. Shiloh R., Weizman A., Epstein Y., Rosenberg S., Valevski A., Dorfman-Etrog P., et al. Abnormal thermoregulation in drug-free male schizophrenia patients. Eur. Neuropsychopharmacol. 11 (2001) 285-288
71. Shiloh R., Bodinger L., Katz N., Sigler M., Stryjer R., Hermesh H., et al. Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patients. Neuropsychobiology 48 (2003) 1-4
72. Shiloh R., Portuguese S., Bodinger L., Katz N., Sigler M., Hermesh H., et al. Increased corneal temperature in drug-free male schizophrenia patients. Eur. Neuropsychopharmacol. 13 (2003) 49-52
73. Shiloh R., Munitz H., Portuguese S., Gross-Isseroff R., Sigler M., Bodinger L., et al. Corneal temperature in schizophrenia patients. Int. J. Neuropsychopharmacol 8 (2005) 1-11
74. Shiloh R., Shapira A., Potchte O., Hermesh H., Popper M., and Weizman A. Effects of climate on admission rates of schizophrenia patients to psychiatric hospitals. Eur. Psychiatry 20 (2005) 61-64
75. Shiloh R., Munitz H., Stryjer R., and Weizman A. A significant correlation between ward temperature and the severity of symptoms in schizophrenia inpatients - a longitudinal study. Eur. Neuropsychophamacol. 17 (2007) 478-482
76. Sidorov A. Effect of temperature on synaptic transmission between identified neurons of the mollusc Lymnaea stagnalis. Neurosci. Lett. 333 (2002) 1-4
77. Snyder S.H. Biochemical factors in schizophrenia. Hosp. Pract. 12 (1977) 133-140
78. Snyder S.H. Dopamine receptors, neuroleptics, and schizophrenia. Am. J. Psychiatry 138 (1981) 460-464
79. Snyder S.H. Neurotransmitters and CNS disease. Schizophr. Lancet 2 (1982) 970-974
80. Snyder S.H. Psychotogenic drugs as models for schizophrenia. Neuropsychopharmacology 1 (1988) 197-199
81. Spivak B., Weizman A., Wolovick L., Hermesh H., Tyano S., and Munitz H. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment. Acta Psychiatr. Scand. 81 (1990) 168-169
82. Suzuki M., Kurachi M., Kawasaki Y., Kiba K., and Yamaguchi N. Left hypofrontality correlates with blunted affect in schizophrenia. Jpn. J. Psychiatr. Neurol. 46 (1992) 653-657
83. Tooley J.R., Eagle R.C., Satas S., and Thoresen M. Significant head cooling can be achieved while maintaining normothermia in the newborn piglet. Arch. Dis. Child., Fetal Neonatal Ed. 90 (2005) 262-266
84. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., and Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatr. Res. 110 (2002) 249-257
85. Weinberger D.R., and Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 16 (1995) 87-110
86. Weinberger D.R., Torrey E.F., Neophytides A.N., and Wyatt R.J. Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch. Gen. Psychiatry. 36 (1979) 735-739
87. Weinberger D.R., Wagner R.L., and Wyatt R.J. Neuropathological studies of schizophrenia: a selective review. Schizophr. Bull. 9 (1983) 193-212
88. Weinberger D.R., Zigun J.R., Bartley A.J., Jones D.W., and Torrey E.F. Anatomical abnormalities in the brains of monozygotic twins discordant and concordant for schizophrenia. Clin. Neuropharmacol. 15 (1992) 122A-123A
89. Wolkin A., Sanfilipo M., Wolf A.P., Angrist B., Brodie J.D., and Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Arch. Gen. Psychiatry 49 (1992) 959-965
90. Zhang S., Sherry A., and Maiioy C. Paracest agent: novel probes for MR thermometry. Proc. ISMRM, 13th Ann. Sci. Mtg, Miami, Florida, USA (2005) 2707
91. Zhu M., Ackerman J., and Yablonskiy D. MR spectroscopic measurement of inhomogeneous temperature distribution in the rat brain. Proc. ISMRM, 13th Ann. Sci. Mtg. Miami, Florida, USA (2005) 551
92. Zhu M., Ackerman J.J., Sukstanskii A.L., and Yablonskiy D.A. How the body controls brain temperature: the temperature shielding effect of cerebral blood flow. J. Appl. Physiol. 101 5 (2006) 1481-1488